Skip to content

Intellia Therapeutics NTLA Total Current Assets

Total Current Assets at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$2.94B+21.4%
ALN
Alnylam PharmaceuticalsALNY
$4.22B+29.1%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$2.45B+31.1%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$1.27B+1.6%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$466.5M-9.0%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$784.74M+19.4%

Other financials

Income statement

See full
Revenue$15.0M-9.5%
Operating income-$100.5M+16.8%
Net income-$96.2M+15.8%
EPS (diluted)-$0.81+26.4%

Balance sheet

See full
Cash & equivalents$134.7M+6.2%
Total debt$80.5M-32.5%
Total equity$620.9M-20.4%
Total assets$758.8M-23.1%

Cash flow

See full
Operating cash flow-$117.3M+21.2%
CapEx$79.0K-89.3%
Free cash flow-$117.4M+21.5%

Valuation

See full
Market cap$2.13B+106%
Enterprise value$2.08B+100%
P/S32.2×+9.5×

Profitability

See full
Operating margin-636.6%-202pp
Net margin-597%-194pp
FCF margin-550.2%-140pp

Returns & leverage

See full
Return on equity-56.3%-1.5pp
Debt / equity0.1×0.0×
Current ratio6.1×+1.2×

Where this comes from

Reported directly by Intellia Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Intellia Therapeutics's total current assets?
Intellia Therapeutics (NTLA) reported total current assets of $466.45M in Q1 2026.
How has Intellia Therapeutics's total current assets changed year-over-year?
Intellia Therapeutics's total current assets decreased by 15.4% year-over-year, from $551.39M to $466.45M.
What is the long-term trend for Intellia Therapeutics's total current assets?
Over 5 years (2020 to 2025), Intellia Therapeutics's total current assets has grown at a -3.1% compound annual growth rate (CAGR), from $616.52M to $527.71M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.